|
1
|
Alberg AJ, Ford JG and Samet JM; American
College of Chest Physicians: Epidemiology of lung cancer: ACCP
evidence-based clinical practice guidelines (2nd edition). Chest.
132(Suppl 3): 29S–55S. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xie L, Yang Z, Li G, Shen L, Xiang X, Liu
X, Xu D, Xu L, Chen Y, Tian Z, et al: Genome-wide identification of
bone metastasis-related microRNAs in lung adenocarcinoma by
high-throughput sequencing. PLoS One. 8:e612122013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang YK, Zhu WY, He JY, Chen DD, Huang
YY, Le HB and Liu XG: miRNAs expression profiling to distinguish
lung squamous-cell carcinoma from adenocarcinoma subtypes. J Cancer
Res Clin Oncol. 138:1641–1650. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng D, Haddadin S, Wang Y, Gu LQ, Perry
MC, Freter CE and Wang MX: Plasma microRNAs as novel biomarkers for
early detection of lung cancer. Int J Clin Exp Pathol. 4:575–586.
2011.PubMed/NCBI
|
|
6
|
Landi MT, Zhao Y, Rotunno M, Koshiol J,
Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola
FM, et al: MicroRNA expression differentiates histology and
predicts survival of lung cancer. Clin Cancer Res. 16:430–441.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu SL, Chen HY, Chang GC, Chen CY, Chen
HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, et al: MicroRNA
signature predicts survival and relapse in lung cancer. Cancer
Cell. 13:48–57. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang R, Chen XF and Shu YQ: Prediction of
non-small cell lung cancer metastasis-associated microRNAs using
bioinformatics. Am J Cancer Res. 5:32–51. 2015.PubMed/NCBI
|
|
10
|
Larzabal L, de Aberasturi AL, Redrado M,
Rueda P, Rodriguez MJ, Bodegas ME, Montuenga LM and Calvo A:
TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205
activity to promote metastasis. Br J Cancer. 110:764–774. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reimers M and Carey VJ: Bioconductor: An
open source framework for bioinformatics and computational biology.
Methods Enzymol. 411:119–134. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk - database: Prediction of possible miRNA binding sites by
'walking' the genes of three genomes. J Biomed Inform. 44:839–847.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo Z, Zhang L, Li Z, Li X, Li G, Yu H,
Jiang C, Dai Y, Guo X, Xiang J, et al: An in silico analysis of
dynamic changes in microRNA expression profiles in stepwise
development of naso-pharyngeal carcinoma. BMC Med Genomics.
5:32012. View Article : Google Scholar
|
|
14
|
Lionetti M, Biasiolo M, Agnelli L,
Todoerti K, Mosca L, Fabris S, Sales G, Deliliers GL, Bicciato S,
Lombardi L, et al: Identification of microRNA expression patterns
and definition of a microRNA/mRNA regulatory network in distinct
molecular groups of multiple myeloma. Blood. 114:e20–e26. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Enerly E, Steinfeld I, Kleivi K, Leivonen
SK, Aure MR, Russnes HG, Rønneberg JA, Johnsen H, Navon R, Rødland
E, et al: miRNA-mRNA integrated analysis reveals roles for miRNAs
in primary breast tumors. PLoS One. 6:e169152011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tabas-Madrid D, Nogales-Cadenas R and
Pascual-Montano A: GeneCodis3: A non-redundant and modular
enrichment analysis tool for functional genomics. Nucleic Acids
Res. 40:W478–W483. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Altermann E and Klaenhammer TR:
PathwayVoyager: Pathway mapping using the Kyoto Encyclopedia of
Genes and Genomes (KEGG) database. BMC Genomics. 6:602005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang LK, Hsiao TH, Hong TM, Chen HY, Kao
SH, Wang WL, Yu SL, Lin CW and Yang PC: MicroRNA-133a suppresses
multiple oncogenic membrane receptors and cell invasion in
non-small cell lung carcinoma. PLoS One. 9:e967652014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mairinger FD, Ting S, Werner R, Walter RF,
Hager T, Vollbrecht C, Christoph D, Worm K, Mairinger T,
Sheu-Grabellus SY, et al: Different micro-RNA expression profiles
distinguish subtypes of neuroendocrine tumors of the lung: results
of a profiling study. Mod Pathol. 27:1632–1640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aguirre-Gamboa R, Gomez-Rueda H,
Martínez-Ledesma E, Martínez-Torteya A, Chacolla-Huaringa R,
Rodriguez-Barrientos A, Tamez-Peña JG and Treviño V: SurvExpress:
An online biomarker validation tool and database for cancer gene
expression data using survival analysis. PLoS One. 8:e742502013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Du L, Schageman JJ, Subauste MC, Saber B,
Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD, et al:
miR-93, miR-98, and miR-197 regulate expression of tumor suppressor
gene FUS1. Mol Cancer Res. 7:1234–1243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li F, Li XJ, Qiao L, Shi F and Liu W, Li
Y, Dang YP, Gu WJ, Wang XG and Liu W: miR-98 suppresses melanoma
metastasis through a negative feedback loop with its target gene
IL-6. Exp Mol Med. 46:e1162014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kitamura K, Seike M, Okano T, Matsuda K,
Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K and Gemma A:
miR-134/487b/655 cluster regulates TGF-β-induced
epithelial-mesenchymal transition and drug resistance to gefitinib
by targeting MAGI2 in lung adenocarcinoma cells. Mol Cancer Ther.
13:444–453. 2014. View Article : Google Scholar
|
|
25
|
Kim J, Lim NJ, Jang SG, Kim HK and Lee GK:
miR-592 and miR-552 can distinguish between primary lung
adenocarcinoma and colorectal cancer metastases in the lung.
Anticancer Res. 34:2297–2302. 2014.PubMed/NCBI
|
|
26
|
Ma J, Mannoor K, Gao L, Tan A, Guarnera
MA, Zhan M, Shetty A, Stass SA, Xing L and Jiang F:
Characterization of microRNA transcriptome in lung cancer by
next-generation deep sequencing. Mol Oncol. 8:1208–1219. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boyerinas B, Park SM, Hau A, Murmann AE
and Peter ME: The role of let-7 in cell differentiation and cancer.
Endocr Relat Cancer. 17:F19–F36. 2010. View Article : Google Scholar
|
|
28
|
Ali S, Saleh H, Sethi S, Sarkar FH and
Philip PA: MicroRNA profiling of diagnostic needle aspirates from
patients with pancreatic cancer. Br J Cancer. 107:1354–1360. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nagadia R, Pandit P, Coman WB,
Cooper-White J and Punyadeera C: miRNAs in head and neck cancer
revisited. Cell Oncol (Dordr). 36:1–7. 2013. View Article : Google Scholar
|
|
30
|
Liu X, Chen Z, Yu J, Xia J and Zhou X:
MicroRNA profiling and head and neck cancer. Comp Funct Genomics.
2009:8375142009. View Article : Google Scholar :
|
|
31
|
Kolenda T, Przybyła W, Teresiak A,
Mackiewicz A and Lamperska KM: The mystery of let-7d - a small RNA
with great power. Contemp Oncol (Pozn). 18:293–301. 2014.
|
|
32
|
Peng XC, Gong FM, Zhao YW, Zhou LX, Xie
YW, Liao HL, Lin HJ, Li ZY, Tang MH and Tong AP: Comparative
proteomic approach identifies PKM2 and cofilin-1 as potential
diagnostic, prognostic and therapeutic targets for pulmonary
adenocarcinoma. PLoS One. 6:e273092011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shi HS, Li D, Zhang J, Wang YS, Yang L,
Zhang HL, Wang XH, Mu B, Wang W, Ma Y, et al: Silencing of pkm2
increases the efficacy of docetaxel in human lung cancer xenografts
in mice. Cancer Sci. 101:1447–1453. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Anumanthan G, Halder SK, Friedman DB and
Datta PK: Oncogenic serine-threonine kinase receptor-associated
protein modulates the function of Ewing sarcoma protein through a
novel mechanism. Cancer Res. 66:10824–10832. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Carter JJ, Feingold DL, Oh A, Kirman I,
Wildbrett P, Stapleton G, Asi Z, Fowler R, Bhagat G, Huang EH, et
al: Perioperative immunomodulation with Flt3 kinase ligand or a
whole tumor cell vaccine is associated with a reduction in lung
metastasis formation after laparotomy in mice. Surg Innov.
13:41–47. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chakravarty PK, Alfieri A, Thomas EK, Beri
V, Tanaka KE, Vikram B and Guha C: Flt3-ligand administration after
radiation therapy prolongs survival in a murine model of metastatic
lung cancer. Cancer Res. 59:6028–6032. 1999.
|
|
37
|
Sasi W, Sharma AK and Mokbel K: The role
of suppressors of cytokine signalling in human neoplasms. Mol Biol
Int. 2014:6307972014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ge D, Gao AC, Zhang Q, Liu S, Xue Y and
You Z: LNCaP prostate cancer cells with autocrine interleukin-6
expression are resistant to IL-6-induced neuroendocrine
differentiation due to increased expression of suppressors of
cytokine signaling. Prostate. 72:1306–1316. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Karakaidos P, Taraviras S, Vassiliou LV,
Zacharatos P, Kastrinakis NG, Kougiou D, Kouloukoussa M, Nishitani
H, Papavassiliou AG, Lygerou Z, et al: Overexpression of the
replication licensing regulators hCdt1 and hCdc6 characterizes a
subset of non-small-cell lung carcinomas: Synergistic effect with
mutant p53 on tumor growth and chromosomal instability - evidence
of E2F-1 transcriptional control over hCdt1. Am J Pathol.
165:1351–1365. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li JN, Feng CJ, Lu YJ, Li HJ, Tu Z, Liao
GQ and Liang C: mRNA expression of the DNA replication-initiation
proteins in epithelial dysplasia and squamous cell carcinoma of the
tongue. BMC Cancer. 8:3952008. View Article : Google Scholar
|
